Democratic Republic of Congo's Ebola response committee will start using the second Ebola vaccine next month. The head of the committee, Dr. Jean-Jacques Muyembe said the Ad26-ZEBOV-GP vaccine manufactured by Johnson & Johnson's Belgian subsidiary will be used for vaccination in three eastern provinces.